Gross Margin

Gross Margin represents the percentage of revenue a company keeps after paying the direct costs of producing its goods—here, 45.7% means BDX retains $0.457 of every dollar of sales after paying for manufacturing or supply costs.

This result lies well below the Healthcare sector median of 69.8%, placing BDX in the 18th percentile among its peers—meaning most competitors generate a larger profit buffer from their sales. No trend data are available: the year-over-year change is N/A, the quarter-over-quarter change is N/A, and only a single historical value (45.7%) was provided, so no direction can be assessed. The combination of a low margin relative to the sector and the absence of any trend information leaves investors with an unclear risk profile—the level itself suggests below-average profitability, but without a trend it is impossible to tell if this is improving or worsening. This metric does not contradict the overall NEUTRAL verdict; it introduces a cautionary factor (low profitability versus peers) but is countered by other elements in the analyst’s assessment, keeping the rating balanced rather than bullish or bearish.

Frequently Asked Questions

Closest Sector Peers